Cargando…

The Future of GDNF in Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Manfredsson, Fredric P., Polinski, Nicole K., Subramanian, Thyagarajan, Boulis, Nicholas, Wakeman, Dustin R., Mandel, Ronald J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750181/ https://www.ncbi.nlm.nih.gov/pubmed/33364933 http://dx.doi.org/10.3389/fnagi.2020.593572

Ejemplares similares

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
por: d’Anglemont de Tassigny, Xavier, et al.
Publicado: (2015)

Loss of Functional Alpha-Synuclein: A Toxic Event in Parkinson’s Disease?
por: Kanaan, Nicholas M., et al.
Publicado: (2012)

Stress-Induced Executive Dysfunction in GDNF-Deficient Mice, A Mouse Model of Parkinsonism
por: Buhusi, Mona, et al.
Publicado: (2016)

The contribution of alpha synuclein to neuronal survival and function – Implications for Parkinson's disease
por: Benskey, Matthew J., et al.
Publicado: (2016)

Ultrasound-Triggered Effects of the Microbubbles Coupled to GDNF Plasmid-Loaded PEGylated Liposomes in a Rat Model of Parkinson's Disease
por: Yue, Peijian, et al.
Publicado: (2018)

Serum glial cell line-derived neurotrophic factor (GDNF) a potential biomarker of executive function in Parkinson’s disease
por: Tong, Shu-Yan, et al.
Publicado: (2023)

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
por: Penttinen, Anna-Maija, et al.
Publicado: (2018)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington’s Disease
por: Chakroborty, Shreaya, et al.
Publicado: (2020)

Impaired Latent Inhibition in GDNF-Deficient Mice Exposed to Chronic Stress
por: Buhusi, Mona, et al.
Publicado: (2017)

Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease
por: Chu, Yaping, et al.
Publicado: (2020)

Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
por: Zhao, Yuling, et al.
Publicado: (2022)

GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model
por: Zhao, Yuling, et al.
Publicado: (2014)

GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop
por: Barker, Roger A., et al.
Publicado: (2020)

Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
por: Benskey, Matthew J., et al.
Publicado: (2018)

Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2016)

An Update on Medical and Surgical Treatments of Parkinson’s Disease
por: Nemade, Dipali, et al.
Publicado: (2021)

Blueberry juice augments exercise-induced neuroprotection in a Parkinson’s disease model through modulation of GDNF levels
por: Castro, Sandra L., et al.
Publicado: (2022)

Future Therapeutic Strategies for Freezing of Gait in Parkinson’s Disease
por: Cui, Cathy K., et al.
Publicado: (2021)

Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson’s Disease with Sleep Disorders
por: Wang, Li, et al.
Publicado: (2023)

Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson’s Disease. A Systematic Review
por: Kambey, Piniel Alphayo, et al.
Publicado: (2021)

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Correction to: Ret is essential to mediate GDNF’s neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2018)

Effects of transplanted GDNF gene modified marrow stromal cells on focal cerebral ischemia in rats
por: Wang, Yunliang, et al.
Publicado: (2011)

Parkinson’s Disease and the Gut: Future Perspectives for Early Diagnosis
por: Harsanyiova, Jana, et al.
Publicado: (2020)

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

Will Crystal Parkin Help in Understanding the Future of Parkinson’s Disease?
por: Olszewska, Diana Angelika, et al.
Publicado: (2015)

Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson’s Disease
por: Fan, Ching-Hsiang, et al.
Publicado: (2016)

Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease
por: Chen, Cang, et al.
Publicado: (2019)

Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson’s disease
por: Tang, Chuan-Xi, et al.
Publicado: (2022)

Simultaneous Detection of Both GDNF and GFRα1 Expression Patterns in the Mouse Central Nervous System
por: Ortega-de San Luis, Clara, et al.
Publicado: (2016)

Impact of age and vector construct on striatal and nigral transgene expression
por: Polinski, Nicole K, et al.
Publicado: (2016)

Back to the future: lessons from past viral infections and the link with Parkinson’s disease
por: Dowd, Eilis, et al.
Publicado: (2021)

Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson’s Disease
por: Garea-Rodríguez, Enrique, et al.
Publicado: (2016)

Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson’s Model
por: Lai, Jessica IChi, et al.
Publicado: (2023)

Increased Endogenous GDNF in Mice Protects Against Age-Related Decline in Neuronal Cholinergic Markers
por: Mitra, Sumonto, et al.
Publicado: (2021)

Parkinson's Disease: General Features, Effects of Levodopa Treatment and Future Directions
por: Freire, Marco Aurélio M., et al.
Publicado: (2010)

A Method for Combining RNAscope In Situ Hybridization with Immunohistochemistry in Thick Free-Floating Brain Sections and Primary Neuronal Cultures
por: Grabinski, Tessa M., et al.
Publicado: (2015)

Transgenic GDNF Positively Influences Proliferation, Differentiation, Maturation and Survival of Motor Neurons Produced from Mouse Embryonic Stem Cells
por: Cortés, Daniel, et al.
Publicado: (2016)

Co-targeting myelin inhibitors and CSPGs markedly enhances regeneration of GDNF-stimulated, but not conditioning-lesioned, sensory axons into the spinal cord
por: Zhai, Jinbin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_beem6qsbtpmdo0ptg3ege34v64